Astrazeneca plc - ADR

AZN

$54.88

+10.1% (1 year change)

Market Cap

$175 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$46.11 - $64.21

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

117.31x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.39 (2.47%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $175 Billion
Enterprise Value $199 Billion
Dividend Yield $1.39 (2.47%)
1 Year Return +12.5%
52-Week High $64.21
52-Week Low $46.11
Beta 0.37
Outstanding Shares 3.1 Billion
Avg 30 Day Volume 5.04 Million

Valuation

P/E Ratio 117.31
PEG -33.17
Earnings per Share $0.55
Price to Sales Ratio 5.49
Price to Book Ratio 4.57
Revenue to Enterprise Value 6.07
EBIT to Enterprise Value 87.38
Total Debt to Enterprise Value 0.16
Debt to Equity 0.8

Profitability

Revenue $32.8 Billion
Gross Profit $23.5 Billion
EBIT $2.28 Billion
Net Income $1.49 Billion
Profit Margin 4.53%
Quarterly Earnings Growth (YoY) -353.6%
Return on Equity 3.74%
Return on Assets 1.39%
Return on Invested Capital 2.73%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Astrazeneca plc - ADR

CEO: Pascal Soriot

Industry: Pharmaceuticals: Major

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Similar stocks

Pfizer Inc.
Merck & Co Inc
Glaxosmithkline plc - ADR
Sanofi - ADR
Lilly(Eli) & Co
Johnson & Johnson
Abbott Laboratories
Biogen Inc
Novartis AG - ADR

News